Skip to main content
Log in

Studies on development of resistant strains to antibiotics and antituberculosis agents(II) isolation of rifampicin resistant mutants fromClostridium butyricum

  • Original Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The preparation ofClostridium butyricum is used as a normalizing agent for human intestinal flora. When the microbe is simultaneously used with rifampicin, it is inactivated by the antibiotic. To develop rifampicin-resistant mutants, rifampicin-sensitive strain Miyairi II 588 ofC. butyricum was treated with nitrosoguanidine (NTG). To ensure stable resistance to rifampicin, we examined whether the resistance was plasmid-mediated or chromosome-mediated. It was found that the resistance of four mutant strains was not mediated by its inherent plasmid, but by the chromosomal mutation. These strains were examined for the susceptibility and resistance to other antituberculosis agents and antibiotics. The results showed that these mutants were resistant to the high concentration of the antituberculosis agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. Miyairi, Y.:Clostridium butyricum Miyairi and its spores for intestinal disorder. Japan, 77 48, 169 (Cl. A61k35/74), 08 Dec. 1977, Appl. 68/88, 484, 03 Dec. 1968.

  2. Mose, J.R. and Mose, G.: Onkolyseversuchemit Apathogenen, Anaeroben Sporenbildern am Enrich-Tumor der Maus.Z. Krebsforsch. 63, 63–74 (1979).

    Google Scholar 

  3. Hara, H., Yoshinaga, Y. and Nagai, T.: Oral drugs for the prevention of dysentery in a dormitory. J. Kurume Med. Assoc. bd27, No. 23 (1964).

  4. Kobayashi, S. and Tanami, J.: Effects of Oral Administration of Miyarisan, a Preparation Composed byClostridium butyricum spores, on the Intestinal Bacterial Flora of Infants.J. Chiba Med. 44, 185–192 (1968).

    Google Scholar 

  5. Kim, H.S., Kim, J.W., Lee S.H., Choi, E.C. and Kim, B.K.: Susceptibility and Resistance ofLactobacilli andClostridium in the Commerically Available Preparations to Antituberculosis Agents and Antibiotics.Yakhak Hoeji 29, 159–165 (1985).

    CAS  Google Scholar 

  6. Gerhard, G., Jan, R.A. and Hans, H.: The Genus Clostridium (Nonmedical Aspects).The Prokaryotes 2, 1767–1803 (1981).

    Google Scholar 

  7. Schwartz, A.C. and Stadtman, T.C.: Small colonies ofClostridium sticklandii resulting from nitrosoguanidine treatment and exhibiting defects in catabolic enzymes.J. Bacteriol. 104, 1242–1245 (1970).

    PubMed  CAS  Google Scholar 

  8. Thompon, L.A., Gates, D.M., Ingledew, W.M. and Jones, G.A.: Use of the hungate anaerobic technique in the isolation of pholroglucinol-negative mutants ofCoporococcus species.Appl. Environ. Microbiol. 31, 21–24 (1976).

    Google Scholar 

  9. Bouanchaud, D.H., Scavizzi, M.R. and Chabeert, Y.A.: Elimination by ethidium bromide of antibiotic resistance inEnterobacterial andStaphylococci.J. Gen. Microbiol. 54, 417–425 (1969).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, H.S., Choi, F.C. & Kim, B.K. Studies on development of resistant strains to antibiotics and antituberculosis agents(II) isolation of rifampicin resistant mutants fromClostridium butyricum . Arch. Pharm. Res. 11, 218–224 (1988). https://doi.org/10.1007/BF02861312

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02861312

Keywords

Navigation